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Amyloidogenesis is a characteristic feature of the 40 or so known protein deposition diseases, and accumulating evidence strongly suggests
that self-association of misfolded proteins into either fibrils, protofibrils, or soluble oligomeric species is cytotoxic. The most likely mechanism for
toxicity is through perturbation of membrane structure, leading to increased membrane permeability and eventual cell death. There have been a
rather limited number of investigations of the interactions of amyloidogenic polypeptides and their aggregated states with membranes; these are
briefly reviewed here. Amyloidogenic proteins discussed include A-beta from Alzheimer's disease, the prion protein, α-synuclein from
Parkinson's disease, transthyretin (FAP, SSA amyloidosis), immunoglobulin light chains (primary (AL) amyloidosis), serum amyloid A
(secondary (AA) amyloidosis), amylin or IAPP (Type 2 diabetes) and apolipoproteins. This review highlights the significant role played by
fluorescence techniques in unraveling the nature of amyloid fibrils and their interactions and effects on membranes. Fluorescence spectroscopy is a
valuable and versatile method for studying the complex mechanisms of protein aggregation, amyloid fibril formation and the interactions of
amyloidogenic proteins with membranes. Commonly used fluorescent techniques include intrinsic and extrinsic fluorophores, fluorescent probes
incorporated in the membrane, steady-state and lifetime measurements of fluorescence emission, fluorescence correlation spectroscopy,
fluorescence anisotropy and polarization, fluorescence resonance energy transfer (FRET), fluorescence quenching, and fluorescence microscopy.
© 2007 Elsevier B.V. All rights reserved.Keywords: Amyloid; Fibrils; Fluorescence probes; Oligomers; Protofibrils; Membrane permeability; Aggregation; Toxicity; Fluorescence resonance energy transfer;
Fluorescence correlation spectroscopy; Fluorescence anisotropy
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The discovery of amyloid fibrils as a major constituent of
protein deposition in various tissues and correlation of their
accumulation with various diseases states has led to intense
study of the formation and structure of such fibrils, and their
interaction with possible targets such as membranes. In this
review, we emphasize the advantages of fluorescence spectro-
scopy in such investigations and analyze recently published
data for a number of polypeptide systems (Fig. 1).
Fluorescence spectroscopy is one of the most powerful
methods to study protein folding, dynamics, assembly, and
interactions, as well as membrane structure. It has been
successfully applied to investigate the complex mechanisms
of protein aggregation including amyloid fibril formation and
the interaction of amyloidogenic proteins with membranes, as
well as their dynamic structures. The power of fluorescence
spectroscopy lies in its broad applicability. Almost all proteins
have natural fluorophores, tyrosine and tryptophan residues,
which allow study of changes in protein conformation. Also
site-specific labeling with external fluorophores is easily
achievable by mutagenesis and chemical modifications. Fluor-
escence spectroscopy requires a small amount of material (pM–nM range) and has a high signal-to-noise ratio. It is a convenient
method to study fast protein conformational changes because
the fluorescence emission lifetime is in the nanosecond range,
which is relatively fast compared to most conformational
transitions. It is also used in single-molecule, imaging and
kinetics studies. Fluorescent studies of amyloidogenic proteins
have been very insightful and demonstrate the importance of
using fluorescence spectroscopy as an alternative or comple-
mentary technique to EPR, CD, FTIR, NMR, and fiber
diffraction, in obtaining structural information.
2. General methods of fluorescence spectroscopy
2.1. Intrinsic fluorophores
Tryptophan (Trp) and tyrosine (Tyr) residues are naturally
occurring fluorophores in proteins. Trp has the highest quantum
yield and its emission maximum is sensitive to the polarity of its
environment; consequently, Trp is a commonly used intrinsic
fluorescent probe in studying protein folding and dynamics. The
λmax of a buried Trp is around 335 nm, whereas fully solvent
accessible Trp has λmax around 355 nm. Trp fluorescence
lifetime measurements can overcome the limitations of steady-
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lifetimes or anisotropy of different residues. Usually, the
exponential decay does not follow a single exponent, indicating
the existence of several different excited states of the
fluorophore. It is also possible to analyze the steady-state Trp
spectrum by applying second derivative analysis [1]. Tyr has
significantly lower quantum yield than Trp and is usually only
used as an intrinsic fluorescent probe in Trp-lacking proteins or
peptides, since energy transfer to Trp residues usually quenches
the Tyr fluorescence. The Tyr emission maximum is near 305 nm
and is not sensitive to the polarity of environment; however, Tyr
emission depends on pH. The phenolic hydroxyl group has a pKa
near 10 and at high pH is deprotonated. The deprotonation
results in the formation of tyrosinate, which has a red-shifted
emission spectrum (λmax 340 nm). Phe has a very low quantum
yield, and is usually not used as a fluorescent probe. The close
proximity of Phe to Tyr or Trp, and Tyr to Trp, can influence the
quantum yield of Trp and Tyr through energy transfer.
2.2. Extrinsic fluorophores
Thioflavin T (4-(3,6-dimethylbenzothiazol-2-yl)-N,N-
dimethyl-aniline, ThT), Fig. 2A, and 1-anilinonaphthalene-8-
sulfonic acid (ANS) are commonly used non-covalent extrinsic
fluorescent probes in studies of protein folding and amyloid
fibril formation. The quantum yield of ANS is increased up to
100 times upon binding to hydrophobic regions of a protein. The
partially folded and molten globule states of a protein are the
most accessible forms for ANS binding. Because of this, ANS is
widely used to detect and characterize protein-folding inter-
mediates. The binding of ANS is accompanied by a blue shift of
the emission maximum (from ∼530 nm to ∼475 nm) [2].
ThT is used as a specific probe for the presence of amyloid
fibrils, Fig. 2B, C [3,4]. It has a two-ring structure: the
conjugated benzothiazol and aminobenzol rings are arranged in
an almost planar orientation (ϕ∼30 °) in the minimum energy
conformation, Fig. 2A [5]. During excitation, the rings rotate in
order to obtain the most stable exited state conformation
(ϕ∼90 °), which has low fluorescence efficiency. Polar
solvents and viscosity can affect the reorientation of the rings
and as a result the ThT fluorescence. The binding to amyloid
fibrils probably stabilizes the planar form of the molecule and
leads to a 10–500-fold increase in ThT fluorescence intensity. It
is tempting to speculate that ThT may bind between the beta-
sheets of the fibril, however, no experimental data exist to
support this assumption. Puzzlingly, ThT has two excitation
(∼335 nm and ∼430 nm) and two corresponding emission
peaks (∼425–455 nm and 483 nm): an increase of ThT
concentration results in a red shift of the λmax from 425 nm to
455 nm. Excitation at∼350 nm results in emission at∼438 nm,
whereas excitation at ∼440 nm leads to emission at 483 nm.
Binding to amyloid fibrils induces a blue shift of the ThT λmax
from 483 nm to 478 nm. The excitation spectra show that only
the peak around 430 nm increases upon ThT binding to fibrils. It
is possible that the two peaks correspond to two conformations
of the ThT molecule (planar and twisted). The binding to fibrils
can be also detected by FRET between Tyr or Trp of the fibrillarprotein and ThT (Fig. 2D, E). One possible explanation is that
ThT (twisted or freely-rotating conformation) can absorb at
330–350 nm, converts into the planar conformation, and emits
light at ∼480 nm.
Several fluorescent dyes are more or less specific to various
conformational states of proteins, for example, ANS recognizes
partially folded and molten globule states of a protein and
Thioflavin T is relatively specific to amyloid fibrils. The
application of such specific fluorescent dyes to monitor the
kinetics aggregation of amyloidogenic proteins is a valuable
approach to understand the complexity of the multisequential
and parallel pathways of amyloid formation. Currently there are
no specific tools to distinguish oligomers that are direct
precursors of fibrils, from oligomers that are off the fibril
formation pathway. The formation of protofilaments and their
assembly into mature fibril is also poorly understood, because
we do not have specific markers that detect only protofilaments
or only fibrils.
Two types of covalently attached fluorescent probes have
been used in investigations of amyloidogenic proteins with
membranes. The first type involves the attachment of a
fluorophore, usually a derivative of naphthalene, fluorescein
or rhodamine, to the protein, often via a specific Cys thiol
residue, or less specific labeling of lysine residues [6,7]. The
covalently bound probes can then be used in a variety of types
of fluorescent experiments, ranging from simple changes in the
environment of the probe on fibrillation or interaction with a
membrane to FRET studies. The second type of covalent probe
involves intracellular expression of a fusion protein containing
the amyloidogenic polypeptide and a fluorescent tag, usually
either GFP or a homolog [8] or a tetra-Cys motif to bind a
fluorescence arsenic compound e. g. FLASH [9].
2.3. Membrane fluorescent dyes
Membrane fluorescent probes are used for studying lateral
diffusion, fluidity, positioning of lipids and proteins in the lipid
bilayer, and surface potential of membranes [10]. Lateral
diffusion is usually studied by excimer-forming fluorophores
such as pyrene. Excimer emission (due to dye–dye interaction)
is red-shifted in comparison to emission of the monomeric dye.
Fluorescein is another fluorophore, which can be used for
studying lateral diffusion: the dimerization of fluorescein results
in homo-FRET and quenching of fluorescence. The commonly
employed probe 1,6-diphenyl-1,3,5-hexatriene (DPH) is loca-
lized in the lipid bilayer and serves as a sensor of the disordering
of fatty acyl chains that occurs during the transition from gel to
liquid crystalline phase. DPH also detects the perturbation of the
fatty acyl chain packing upon insertion of proteins. The mobility
of DPH within the lipid bilayer restricts the detection of its exact
location and as a result limits the interpretation of data. For this
reason, DPH-phosphatidyl choline or other derivatives are
usually used. Anthroylstearate is another fluorescent probe
detecting lipid dynamics at different depths into the lipid
bilayer. The dansyl (dimethylaminonaphthlenesulfonyl) group
and 2-N-(4-nitrobenzo-2-oxa-1,3-diazole (NBD) attached to the
phospholipid head group are responsive to surface-solvent
Fig. 1. Three-dimensional structures of human amyloidogenic proteins and peptides in their “native” states and their amino acid sequences. Red regions of the sequence
mark the residues for which a 3D-structure has been solved. (A) amyloid beta peptide; (B) prion PrPC; (C) alpha-synuclein (in the presence of SDS micelles); (D)
tetramer of lipid-free apolipoprotein AI; (E) islet amyloid peptide (amylin); (F) variable domain of immunoglobulin light chain SMA; (G) beta2-microglobulin; (H)
transthyretin dimer.
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Fig. 1 (continued).
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weakly fluorescent in water and strongly fluorescent in hydro-
phobic environments. Dansylated lipids and 2-(p-toluidinyl)
naphthalene-6-sulfonate (TNS) have been used to study solvent
relaxation processes in membranes. Fig. 3 shows the structures
of some commonly used fluorescent membrane probes.
2.4. Steady-state and time-resolved spectroscopy
Steady-state measurements are important in the analysis of
changes in the intensity, excitation and emission maxima, and
polarization of fluorophores. However, steady-state spectro-
scopy is inadequate in the analysis of heterogeneous systems
with multiple states of the fluorophore. In addition, intensity
measurements are highly dependent on the fluorophore
concentration and, in cases where small changes have to be
detected, the experimental error can exceed the level of subtle
changes. Time-resolved (lifetime) fluorescence spectroscopy
allows estimates of the lifetime of the fluorophore, which is not
dependent on concentration thus providing more accurate data.
Lifetime measurements are used in anisotropy, energy transfer,
and quenching experiments [11]. The fluorescence decay
analysis based on the discrete multiexponential or lifetime
distribution models permits estimates of the number of different
microenvironments of the fluorophore. The binding and stabi-
lization of the fluorophore usually results in an increase in the
lifetime, whereas quenching decreases the fluorescence lifetime.
2.5. Anisotropy and polarization
The excitation of a fluorophore corresponds to the absorption
of a quantum of radiant energy that results in the transition to a
higher electronic state and internal conversion to the lowestexcited state. This state is achieved in picoseconds before the
emission. Because of the internal conversion of the fluorophore
during excitation, the dipole moments of absorption and
emission are different. The absorption of a photon by the
fluorophore is also dependent on the orientation of the light and
fluorophore. By using polarizers for excitation and emission,
particular fluorophores can be selectively excited and detected.
The excitation with vertically polarized light and detection of
vertically or horizontally polarized emission allows analysis of
the efficiency of polarization of the fluorophore [11,12].
Brownian rotation during excitation/emission affects the
anisotropy of the system. If the rotation is slowed by the
attachment of a fluorophore to a larger molecular species, the
anisotropy will be preserved. Anisotropy is defined as a
difference between intensities of vertically and horizontally
polarized emissions divided by total fluorescence intensity.
Anisotropy is additive and can be used in fluorescence lifetime
measurements. The anisotropy decay can detect different states
of the fluorophore (e. g. bound and unbound states for small
fluorophores or freely rotating and rigid states for chemically
attached fluorophores).
2.6. Quenching
Fluorescence quenching can be dynamic or static. If the
distance between the excited fluorophore and a quencher is
fixed, the quenching is static. Dynamic (collisional) quenching
depends on diffusion. The commonly used quenchers are iodine,
oxygen, and acrylamide. Measuring the fluorophore accessi-
bility to quenching by various types of quenchers allows
estimation of the relative position of fluorophore in the protein or
membrane. The quenching analysis (Stern–Volmer plot)
employs the dependence of the fluorescence intensity on the
Fig. 2. The properties of Thioflavin T. (A) Ball-and-stick model of ThT: the rotational angle is around 30 °. Carbons are dark gray, hydrogens are cyan, nitrogens are
blue, and sulfur is yellow. (B) Time-dependent changes in the emission spectrum of ThT (10 μM) excited at 450 nm in the presence of alpha-synuclein (10 μM). The
increase in ThT intensity with time corresponds to the formation and accumulation of alpha-synuclein fibrils. (C) Kinetics of alpha-synuclein fibril formation
monitored by ThT fluorescence (data derived from B). (D) Emission spectra of a mixture of alpha-synuclein fibrils (10 μg/ml) and ThT in phosphate buffer pH 7.5
exited at 275 nm; ThT concentration is changed from 0 to 16.4 μM. The spectra are corrected by subtraction of the corresponding ThT spectra (inset). The inset figure
shows emission spectra of ThT in the absence of alpha-synuclein; the ThT concentration is changed from 0.83 to 16.4 μM. Note the different scales of fluorescence of
ThT alone and in the presence of fibrils. The emission spectra indicate energy transfer between the Tyr of fibrils (λmax at 305 nm) and ThT. (E) Binding curve of ThT
to fibrils derived from FRET data (D).
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linear concentration dependence, whereas static quenching
deviates from linear dependence. Quenching can be achieved
by Förster dipole–dipole energy transfer, by heavy atoms or
paramagnetic molecules. Commonly used quenching experi-
ments include measurement of solvent exposure, FRET and
binding studies.
2.7. Förster resonance energy transfer (FRET)
FRET is based on the dipolar coupling between the emission
dipole of a donor and the absorption dipole of an acceptor (forreview see [13,14]). For this reason, the donor–acceptor pairs
have to be correctly chosen: the emission spectrum of a donor
should overlap the excitation spectrum of an acceptor. To
minimize the background due to the acceptor excitation without
a donor or the donor emission without acceptor, the excitation
spectrum of a donor should be well separated from the
excitation spectrum of an acceptor and their emission spectra
should not overlap. FRET results in a decrease in donor
emission intensity accompanied by an increase in acceptor
emission intensity (in steady-state studies) or in the decrease of
a donor lifetime in time-resolved studies. FRET efficiency (E)
depends upon the sixth power of the distance between the
Fig. 3. Chemical structures and approximate location of the fluorescent probe for commonly used fluorescent membrane probes; NBD-PC, Laurdan, DPH, and TMA-
DPH in a model DPPS monolayer.
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distance for 50% efficiency of energy transfer. R0 depends on
the relative orientation of the donor and acceptor, the refractive
index (n), the quantum yield of the donor (QD), and the overlap
integral between the acceptor emission and donor excitation (J):
R ¼ R0½ð1 hEiÞ=hEiÞ1=6 ð1ÞR0 ¼ 0:22ðn4QDK2JÞ1=6 ð2Þ
The R0 of commonly used FRET pairs is in the range of
20–60 Å, which allows estimation of distances in the range
from 10 to 100 Å. Because R0 depends on the orientation and
quantum yield of the fluorophores, FRET is a very useful and
sensitive method for folding and membrane interaction studies.
If the distance estimation is the primary focus of research, the
position of the fluorophores (surface exposure, lack of
interactions) as well as their chemical properties (charge,
polarity, mobility) have to be carefully chosen.2.8. Fluorescence correlation spectroscopy
Fluorescence correlation spectroscopy (FCS) is based on
correlation analysis of fluctuations of the fluorescence intensity.
Most experiments employ an autocorrelation function. Thetheory of FCS has been developed and applied to various fields
of fluorescence spectroscopy and microscopy [16–19]. It is
especially valuable in studies where a significant background
affects the direct measurement of fluorescence changes. FCS
also employs a cross-correlation function, which allows
comparison of the changes in two fluorophores residing in
either one or two molecules. The analysis of FCS correlation
curves allows estimation of the diffusion coefficients and rates
of fluorophore transitions. FCS can be applied to study the self-
assembly of macromolecules such as fibril formation or the
interaction of proteins with membranes.
2.9. Fluorescence microscopy methods
Fluorescence microscopy is an invaluable tool to study
cellular processes in vivo. Recently, it has been extensively
applied in single-molecule research including studies on
protein–membrane interactions and macromolecular assembly
[13]. New approaches include total internal reflection, confocal,
and two- or multi-photon fluorescence microscopy. Total
internal reflection fluorescent microscopy (TIRFM) allows
visualization of wide areas but relatively thin regions of the
sample. It is based on the evanescent wave excitation of
fluorophores located less than 200 nm from the glass–water
interface. The evanescent wave is generated when the incident
light is totally reflected from the glass–water interface and its
efficiency to penetrate into the sample decreases exponentially.
1869L.A. Munishkina, A.L. Fink / Biochimica et Biophysica Acta 1768 (2007) 1862–1885TIRFM has been used for studies of cell surface (plasma
membrane) and single-molecule approaches such as fibril
growth [20]. Confocal fluorescence microscopy is better suited
for three-dimensional resolution analysis. The laser beam waist
can be less than one μm in diameter and focused to different
depths. Confocal fluorescence microscopy has limitations in the
detection of UV-excited fluorophores due to the absence of
suitable UV lenses and high photodamage to living cells by UV
lasers. However, two- or multi-photon fluorescence microscopy
allows analysis of UV-excitable fluorescence [21]. Instead of
lenses, two-photon fluorescence microscopy utilizes the
simultaneous acquisition of two photons by the fluorophore,
which results in a quadratic dependence of emission on
excitation intensity. Thus, out-of-plane laser beam regions are
not excited, restricting the detection zone to a small volume.
Two-photon acquisition is achieved by using high output power
and a femtosecond pulsed infrared laser.
3. Folding and amyloid fibril formation of amyloidogenic
proteins
Protein deposition diseases are characterized by accumula-
tion of proteinaceous aggregates frequently composed of
insoluble fibrils. All amyloid fibrils possess cross-beta structure
and consist of one particular protein or peptide. A parallel
arrangement of beta-sheets with β-strands perpendicular to the
axis of the fibril appears to be the major structural feature of
amyloid fibrils [22–26]. However, the native structures of
amyloidogenic proteins differ greatly and several amyloido-
genic proteins are intrinsically disordered or contain highly
flexible unfolded regions (e. g. A-beta, α-synuclein, the N-
terminal domain of the prion protein, tau, the poly(Q) regions of
huntingtin and the ataxins), whereas others are stably folded
monomers, dimers (e. g. immunoglobulin light chains),
tetramers (e. g. transthyretin), hexamers (e. g. insulin) or exist
as a part of larger macromolecular complexes (e. g. beta-2
microglobulin of the major histocompatibility complex I, and
apolipoprotein I and serum amyloid A, which are components
of high density lipoproteins). Their folds are also different from
each other. Insulin, lysozyme, apolipoproteins, serum amyloid
A, the C-terminal of animal prions all contain several α-helices,
whereas beta-2 microglobulin, immunoglobulin light chains,
and transthyretin are folded into beta-sandwiches. Several
amyloidogenic proteins are stabilized by intramolecular dis-
ulfide bonds. The nature of the structural elements guiding
amyloid formation is poorly understood. Such structural
analysis is important in order to understand the pathological
function of amyloid and to find inhibitors that prevent the
formation of toxic species or their interaction with targets such
as cell membranes or the extracellular matrix. The discovery of
transient oligomers of several amyloidogenic proteins poses a
new challenge in order to understand their relation to amyloid
fibrillogenesis and toxicity. The oligomeric species could be
precursors of fibrils or off-pathway intermediates, and have
been proposed to be cytotoxic [27].
In Sections 4 to 12 we review salient experiments concerning
the use of fluorescence to reveal structural informationregarding amyloidogenesis of specific proteins and polypep-
tides (Fig. 1), especially in the presence of membranes.
4. α-Synuclein folding properties, fibril assembly, and
interaction with membranes
Substantial evidence suggests that the aggregation of α-
synuclein is a critical step in the etiology of Parkinson's disease
(PD) [28]. PD is predominantly a movement disorder resulting
from degeneration of dopaminergic neurons in the substantia
nigra. The cause of the disease is unknown, but considerable
evidence suggests a multifactorial etiology involving genetic
susceptibility and environmental factors. Familial early-onset
PD is caused by overexpression of α-synuclein due to
duplication or triplication of the α-synuclein gene locus and
by point mutations that increase the aggregation propensity of α-
synuclein. Based on data obtained by CD, FTIR, SAXS, and
NMR, α-synuclein is an intrinsically disordered or natively
unfolded, protein [29–33]. Analysis of the primary structure
shows three different regions: the N-terminal region consisting
of five degenerate 11-mer repeats (E/G/S) K (T/A) K (E/Q) G V
(V/A/T/L) X (A/V/G) (A/V/G) of overall positive charge, the
hydrophobic central part (known as the NAC region), and the C-
terminal 40 residues, which are highly enriched in negatively
charged amino acids. There are two phenylalanine and four
tyrosine residues in the protein, localized in distinct regions;
Phe4 and Tyr39 are located in theN-terminal region, Phe94 at the
end of the central region, and Tyr125, Tyr133, and Tyr136 at the
end of the C-terminal region. There are no tryptophan residues.
The repeats are predicted to form amphipathic α-helices.
4.1. Intrinsic tyrosine fluorescence
Monitoring intrinsic Tyr fluorescence of α-synuclein
during fibril formation or interaction with lipid vesicles
revealed changes in the shape and intensity of the Tyr
emission spectrum. The pKa of the phenolic hydroxyl group
of Tyr changes from 10 in the ground state to 4–5 in the first
excited singlet state. The excitation of tyrosine can lead to
proton transfer to nearby glutamate or aspartate residues in
the protein, and consequently to a decrease of tyrosine
fluorescence and increase of tyrosinate fluorescence, which is
manifested by a shift in the emission maximum from 305 to
340 nm. The decrease in tyrosinate intensity and correspond-
ing increase in tyrosine intensity parallels the assembly of α-
synuclein into fibrils, whereas interaction with small
unilamellar vesicles decreases the tyrosine intensity and
increases the tyrosinate intensity, Fig. 4 [34]. Far-UV CD
and NMR data show changes in α-synuclein structure from
unfolded to α-helical upon interaction with SDS micelles and
lipid vesicles. The structural transition occurs in the N-
terminal and central parts of the protein, whereas the C-
terminal remains unfolded. Based on this observation, we
infer that the changes in tyrosine–tyrosinate intensities may
depend on Tyr39 located in the N-terminal part of the
protein. The formation of an amphipathic α-helix would lead
to the positioning of Tyr39 in close proximity to Glu35
Fig. 4. Intrinsic fluorescence of α-synuclein during fibrillation. (A) Time-
dependent changes of tyrosine-tyrosinate fluorescence during the incubation of
α-synuclein: 0 h (black circles), 5 h (white circles), 23 h (black triangles), 47 h
(white triangles), 100 hrs (black squares). (B) Fluorescence of α-synuclein
monomer at pH 7.5 (black circles), pH 10.5 (black triangles) and fibrils at pH 7.5
(white circles). (C) Dependence of tyrosinate (346 nm; triangles) and tyrosine
(310 nm; filled circles) fluorescence on time of incubation of α-synuclein.
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fluorescence.
4.2. Fluorescence of tryptophan and tyrosine mutants of
α-Synuclein
Because the λmax of tyrosine is insensitive to its environment
several tryptophan mutants were constructed as fluorescence
probes [35,36]. Investigations of Y39W and Y125W mutants
show that both tryptophans are exposed to solvent inmonomeric unfolded α-synuclein. During fibril formation
Trp39 becomes partially buried in the core of the fibrils, as
revealed by a blue shift in λmax (340 nm), whereas Trp125
remains solvent exposed. Interestingly, at acidic pH the
emission maxima of Y39W and Y125W are 345 and
345.5 nm, indicating the hydrophobic collapse of α-synuclein
under acidic conditions, presumably due to loss of the negative
charges in the C-terminal region, and consistent with previous
studies showing a partially folded intermediate at acidic pH
[37].
4.3. FRET studies
Time-resolved fluorescence resonance energy-transfer
(FRET) measurements were used to study the structure and
dynamics of α-synuclein in three different conditions: at
physiological pH 7.4, acidic pH 4.4, and in the presence of
SDS micelles [38]. Tryptophan and 3-nitrotyrosine at six
different locations in the protein were chosen as donor–acceptor
pairs with a Förster critical distance of 26 Å. The results show
that α-synuclein exists as ensemble of compact and extended
conformations in all tested conditions. In acidic solutions, the
C-terminal of α-synuclein becomes more compact, whereas in
the presence of SDS micelles the N-terminal is more compact
and the C-terminal is more extended.
Fluorescence resonance energy transfer was also used to
analyze the conformational changes of α-synuclein during
aggregation [35]. The triple mutant Y125W, Y133F, Y136F of
α-synuclein has one tyrosine–tryptophan donor–acceptor pair
with a Förster critical distance of 15 Å. The calculated distance
between Y39 and W125 in monomeric α-synuclein is 25 Å,
which decreases during aggregation to 22 Å (early oligomeric
species) and 19 Å (late oligomeric species).
4.4. Alpha-synuclein interactions with lipid membranes
Alpha-synuclein binds preferentially to small unilamellar
vesicles containing acidic phospholipids such as PA, PS, and
PG but not significantly to vesicles with a net neutral charge (e.
g. PC) [32,34,39–42]. Monounsaturated and polyunsaturated
acyl groups in lipid vesicles increase the binding affinity of α-
synuclein [43]. The interaction of α-synuclein with membranes
is complex and dependent on the composition of the
membranes, their curvature, as well as the ratio of membrane
lipids to protein. Far-UV CD and NMR data show that α-
synuclein adopts an α-helical conformation on binding to
membranes [33,44–49]. The N-terminal and central parts of the
protein form a broken α-helix with a distorted twist at residues
43–44 [49] or two helixes with a linker in the 39–44 region
[33,48] (see Fig. 1). Fig. 5 shows a model of α-synuclein
embedded into a phospholipid membrane. Two Lys residues are
in close proximity to the phosphate groups of phospholipids
forming salt-bridges. A Thr residue is embedded into the
hydrophobic core of the bilayer. It is possible that the hydroxyl
group of Thr interacts with the carboxyl group of acyl chains
through hydrogen bonding. A Gln residue occupies an interface
position. In solution, the monomeric Y39W mutant of α-
Fig. 5. A model of α-synuclein embedded into a phospholipid membrane. (A) Cross-sectional view of an amphipathic alpha-helix of alpha-synuclein (residues 21–31,
KTKQGVAEAAG, are shown as a CPK space-filling model) and a monolayer of phospholipids (phosphatidylserine, as a ball-and-stick model). Carbons are gray,
hydrogens are white, nitrogens are blue, oxygens are red, phosphorous are orange. Two Lys residues are in the close proximity to the phosphate groups of
phospholipids forming salt-bridges. AThr residue is embedded into the hydrophobic core of the phospholipids. It is possible that the hydroxyl group of Thr interacts
with the carboxyl group of acyl chain through hydrogen bonding. A Gln residue occupies a water–(protein–lipid) interface position. (B) Top view of the amphipathic
alpha-helix of alpha-synuclein and a monolayer of phospholipids (phosphatidylserine), all molecules are shown as CPK space-filling models. Alpha-synuclein
residues are colored green.
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vesicles, the maximum is shifted to ∼340 nm, indicating a
change from hydrophilic to a significantly more hydrophobic
environment. However, there is no corresponding change in
λmax for the Y125W mutant. The data correlate with NMR
results showing that only the N-terminal and central parts of α-
synuclein interact with lipid vesicles, and are similar to those for
single Trp mutants (F4W, Y39W, and F94W) in the presence of
SDS micelles [38].
If the binding to lipid vesicles and membranes is strong, the
α-helix will be stable and the formation of fibrils or prefibrillar
oligomers, will be slowed or prevented. Under in vitro
conditions of a high ratio of protein to lipid, membranes can
promote the self-association of α-synuclein and accelerate
fibrillation [50–52]. The mechanism of this aggregation is still
unknown. However in the majority of conditions, the interac-
tion with lipid vesicles, especially synthetic acidic phospholi-
pids such as PA and PS, leads to the inhibition of α-synuclein
self-association and prevents aggregation [34,53], Fig. 6.
4.5. Membrane binding of α-synuclein studied by fluorescence
correlation spectroscopy
The membrane binding of the α-synuclein mutant S9C
labeled with Alexa-488 has been analyzed by using fluores-
cence correlation spectroscopy [41]. The method allows the
simultaneous estimation of lipid-bound and free protein by
detecting differences in their diffusion coefficients. The
diffusion time of free protein is ∼250 μs, whereas the diffusion
time of vesicles (SUV of hydrodynamic radius ∼60 nm) is
∼3.8 ms. The results show that α-synuclein binds tightly to
phospholipids with acidic head groups, preferentially to PA
compared to PS. Binding to phospholipids with zwitterionic
head groups such as PC and PE and lipid raft-like vesicles
composed of sphingomyelin and cholesterol is also observed.The binding to PE is stronger than binding to PC. The binding to
raft-like sphingomyelin-cholesterol vesicles is weak and similar
to binding to vesicles of PC. The maximum achievable molar
ratio of total lipid to bound protein was also quantified: as
expected, the molar ratio varied greatly depending on
phospholipid head group and the percentage of negatively
charged phospholipids in the vesicles. For example, for 1:1
POPA/POPC the molar ratio is 1:250, for 1:1 POPS/POPC the
molar ratio decreases to 1:2000, and for 100% POPS the molar
ratio is 1:85. The observation indicates that at least 85
phospholipid molecules are required for the binding of α-
synuclein. The observed number is close to the theoretically
calculated number of 60. In general, the FCS data are in
excellent accord with those derived from other techniques.
4.6. Effects of α-synuclein on membrane properties
The addition of monomeric α-synuclein to synaptic vesicles
[54] or synthetic vesicles composed of brain sphingomyelin,
DPPC, or POPC/POPG [55] increases the anisotropy of DHP, a
fluorescent membrane probe sensitive to the ordering of fatty
acid acyl chains. α-Synuclein not only stabilizes the packing of
the acyl chains but also increases the gel–liquid crystalline
transition temperature [55]. The stabilization of the outer region
of the lipid bilayer has been also detected with the fluorescent
dye Laurdan. Laurdan is a polarity-sensitive, amphiphilic
fluorophore, positioned 5 Å beneath the lipid–water interface.
An increase in the intensity of Laurdan fluorescence and a
decrease in the generalized polarization correspond to penetra-
tion of water molecules into the lipid bilayer. In the presence of
α-synuclein Laurdan fluorescence decreases, and the general
polarization increases, indicating stabilization of the upper
region of the bilayer, and decreased water penetration [34].
The fluorescent dyes Laurdan and NBD have also been used
to probe the effects of α-synuclein oligomers and fibrils on the
Fig. 6. The effect of vesicles on the kinetics of α-synuclein fibrillation. Fibrillation was monitored by ThT fluorescence. Circles, α -synuclein alone. (A) in the presence
of DPPA/DPPC vesicles in the form of non-intravesicular protein SUVs (i. e. there is no protein within the vesicles); (B) intravesicular protein SUVs (i.e. there is
protein within the vesicles); (C) non-intravesicular protein LUVs; D, intravesicular protein LUVs at protein/lipid ratios of 5:1 (inverted triangles), 1:1 (squares), and
1:5 (diamonds). High concentrations of SUVs completely inhibited fibrillation (A and B). From Ref. [53].
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[34]. The addition of oligomeric or fibrillar α-synuclein to
POPS or POPG results in a concentration-dependent increase in
Laurdan fluorescence and a decrease in the emission general-
ized polarization indicating significant perturbation at least of
the upper region of the lipid bilayer. The addition of monomer
results in much smaller effects on the fluorescence intensity and
generalized polarization of Laurdan. The interaction of α-
synuclein oligomers and fibrils with control vesicles of POPC
does not affect the Laurdan fluorescence indicating a lack of
penetration of the protein into the PC bilayer. In this study,
monomeric α-synuclein slightly disrupted the upper region of
the lipid bilayer, which is contradictory to previous studies;
however, the protein–lipid molar ratio was higher in this
research (1:30 in comparison to 1:100–1:500). The higher
protein–lipid molar ratio may induce α-synuclein oligomeriza-
tion or tighter packing of the protein on the lipid bilayer, which
could lead to the destabilization of the lipid vesicles.
The addition of α-synuclein to vesicles containing NBD
increases NBD fluorescence [34]. The fluorophore in NBD is
located near the head group and thus changes of NBD
fluorescence correspond to changes at the water–lipid interface.
Fibrillar and protofibrillar α-synuclein have much strongereffects on NBD fluorescence than the monomer, and no change
of NBD fluorescence is observed in the presence of POPC
vesicles. Overall, the results support increased membrane
perturbation in the presence of protofibrils and fibrils of α-
synuclein and indicate the possible mechanism of their toxicity
to cells. This is also supported by membrane permeability
experiments using the fluorescent dyes calcein and fura-2
[34,56], which show that protofibrils and fibrils of α-synuclein
increase the permeability of vesicles.
4.7. Monitoring fluorescence of α-Synuclein–GFP fusion
proteins in cells
In order to study localization, trafficking, and structural
changes in α-synuclein in living cells, fusion constructs of α-
synuclein and green fluorescent protein (GFP) and its analogs
have been constructed. Recent studies have shown the
successful expression of α-synuclein–GFP fusion proteins in
yeast, HeLa cells, and neurons. Initial studies of α-synuclein–
GFP in the yeast Saccharomyces cerevisiae showed highly
specific localization of the protein at the plasma membrane,
Fig. 7 [57]. In contrast, the α-synuclein mutant A30P, linked to
familial Parkinson's disease, showed only cytosolic distribu-
Fig. 7. Expression of α-synuclein in yeast. Fluorescence microscopy of yeast cells expressing Syn-GFP. In cells carrying one copy of WT or A53T, the protein
concentrated at the plasma membrane, and small amounts concentrated in the cytoplasm. Cells with two copies of WT or A53T showed cytoplasmic inclusions and
reduced membrane localization. When expressed from the 2 μ plasmid, WT and A53T distributions varied from cell to cell, whereas A30P showed a diffuse
cytoplasmic distribution. From Ref. [57].
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affinity of this mutant [58]. However, overexpression of α-
synuclein–GFP leads to the delocalization of the protein from
the plasma membrane and accumulation in cytoplasmic
inclusions [57]. It has been proposed that the cytoplasmic
inclusions may correspond to the aggregated form of α-
synuclein. Some of the inclusions contain ubiquitin and
overall, the accumulation of ubiquitin is increased with the
increased expression of α-synuclein. Impairment of the protein
degradation pathway has also been detected: co-expression of
α-synuclein and an unstable GFP (GFPu), a specific reporter
of proteasome activity in yeast, showed significant accumula-
tion of the GFPu reporter. In addition, expression of α-
synuclein in yeast leads to increased levels of neutral lipids
such as triglycerides and redistribution of vesicles in the cell.
In HeLa cells α-synuclein–GFP behaves as a soluble
cytoplasmic protein [59]. However, after the permeation of
HeLa cells with digitonin the fusion protein was observed in
specific cell structures near the plasma membrane. There was no
retention of the GFP fusion with A30P α-synuclein in
permeabilized cells, consistent with the specificity of binding
of α-synuclein to membrane structures and low affinity of A30P
binding. When α-synuclein was added externally to permeabi-
lized cells it behaves the same as the intracellularly expressed
fusion protein, and is co-localized with MHC class I integral
membrane proteins, CD55 GPI-anchored proteins, and GM1
and PIP2 lipids, components specifically found in lipid rafts.α- Synuclein–GFP fusion proteins are very valuable for
studying the behavior of the protein in live neurons. The
expression of α-synuclein–GFP in hippocampal neurons not
only shows the synaptic localization of the fusion protein, but
also specific interaction with lipid raft-like regions of the
membrane [59]. Fluorescence recovery after photobleaching
(FRAP) experiments show highly dynamic association of α-
synuclein with synaptic vesicles, and rapid exchange of the
protein between neighboring synapses [60]. The stimulation
of hippocampal neurons leads to the rapid dislocation of α-
synuclein from synapses and is followed by a slow recovery
phase. The dispersion of α-synuclein from synaptic vesicles
requires calcium entry and synaptic vesicle exocytosis. The
requirement of exocytosis probably indicates protein dis-
sociation from vesicles docked to the plasma membrane.
Unlike tightly bound synaptic vesicle proteins, α-synuclein is
not found in the perisynaptic region after membrane fusion
(although very low levels have been detected), which
indicates its rapid dissociation from fusing vesicles. Cur-
rently, the pathway α-synuclein follows after exocytosis is
unknown.
In summary, fluorescence techniques have allowed char-
acterization of the interaction of α-synuclein and its various
aggregated states with membranes of different types and shown
that oligomeric and fibrillar forms of the protein cause
substantial perturbation of membranes and likely promote
membrane permeability leading to cytotoxicity.
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formation, and interaction with membranes
A-beta is a product of proteolysis of the amyloid precursor
protein (APP) and contains 39–43 residues. The accumulation
of A-beta in cerebrovascular deposits and senile plaques reflects
the development of neurodegeneration in Alzheimer's disease.
A-beta is amphiphilic and adopts a random coil conformation in
vitro under physiological conditions. In the presence of raft-like
vesicles containing ganglioside clusters, the peptide becomes α-
helical and, with increased concentration of peptide or
incubation time, forms β-sheet-containing fibrils. There are
two phenylalanine and one tyrosine residues in the peptide,
which, in conjunction with extrinsically attached fluorophores,
are used to monitor conformational transitions during aggrega-
tion and binding to membranes.
5.1. A-beta interaction with membranes
A-beta labeled with a 7-diethylaminocoumarin-3-carbonyl
(DAC) group at the N-terminal end shows interaction with raft-
like membranes (SUV and LUV) made of ganglioside GM1,
cholesterol, and sphingomyelin (1:1:1) [61]. The fluorescence
maximum of DAC-A beta is blue-shifted from ∼480 nm to
465 nm and the intensity is greatly increased in the presence of
the vesicles, indicating a change of fluorophore environment
from hydrophilic to hydrophobic. The binding to vesicles was
also confirmed by FRET between DAC-A beta peptide and
BODIPY-labeled vesicles [61].
5.2. Oligomerization of amyloid-beta peptide in the presence of
membranes
Fluorescein with a Förster critical distance R0 of ∼5.6 nm
for homo-FRET can be easily self-quenched. This property of
fluorescein was used to study A-beta oligomerization during
interaction with the lipid bilayer using raft-like LUVs [62]. The
self-quenching kinetics of fluorescein show that dimerization or
oligomerization occurs with a t1/2 around 10 min. Because it
was not clear that the oligomers or dimers were still attached to
the membrane and had similar structure to fibrillar species of A
beta-peptide, a new approach was implemented [62]. The N-
terminally DAC-labeled A beta-peptide aggregates during
several hours of incubation at 37 °C and shows the formation
of excimers with maximum at 520 nm. The spectra of the self-
associated form of A beta in the presence of raft-like membranes
lacks the 520 nm shoulder indicating the absence of excimer
formation, Fig. 8. These interesting results can be explained by
different structures of the N-terminal part of the peptide in the
fibrils and membrane-bound self-assembled complexes. Based
on solid-state NMR [26] and FTIR data [62], the N-terminal is
unstructured in the fibrils and allows the formation of excimers,
whereas in the presence of membranes the N-terminal region
adopts specific structure and could be bound to the membrane
surface preventing the dye–dye interaction. A variety of studies
indicate that the interaction of A beta with membranes is
complex; some investigations show enhanced formation ofaggregates in the presence of membranes, others suggest no
interaction between aggregated A beta and membranes.
5.3. Effects of A-beta on lipid bilayer structure
Fluorescent dyes incorporated into synthetic membranes are
frequently used to monitor membrane dynamics and structure.
As noted, various fluorophores have been incorporated into
different regions of the lipid bilayer and provide an excellent
tool to probe structural changes in distinct lipid bilayer regions.
N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadeca-
noyl-sn-glycero-3-phosphoethanolamine (DPPE-ANS) has the
ANS fluorophore located among the polar head groups of
amphiphilic lipids, whereas with 2-(3-(diphenylhexa-trienyl)
propanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine
(PPC-DPH) and 12-(9-anthroyloxy) stearic acid (AS) the
fluorophores reside in the hydrocarbon core. These dyes were
incorporated into erythrocyte membranes and their anisotropy
was measured in the presence and absence of A-beta and
glycerophosphocholine (GPC) [63], a product of phospholipid
degradation, which is increased in AD brain. Both A-beta and
GPC significantly enhanced only DPPE-ANS anisotropy
indicating increased ordering of the head group region, which
probably reflects the partial penetration of A-beta into the lipid
bilayer. The presence of GPC in the membrane may change the
assembly of the dye between phospholipid head groups and
promote the better penetration of A-beta into lipids. There is
another possibility, namely that GPC weakly binds to A-beta
and stabilizes some particular conformation (or causes dimer-
ization/oligomerization) that is favorable for membrane inter-
action [63]. In a related study aggregated (probably both
fibrillar and oligomeric) A-beta was shown to penetrate into the
lipid bilayer based on the increased anisotropy of the deeply
embedded membrane fluorophore DPH and lack of effect on the
fluorescence anisotropy of TMA-DPH and Laurdan located in
the upper lipid bilayer region [64]. These fluorescence data are
consistent with multiple observations that aggregated A-beta is
more cytotoxic and has greater effects on membrane perme-
ability, and is consistent with the cytotoxic effects emanating
from membrane perturbations.
Real-time fibril growth of A-beta fibrils was monitored by
total internal reflection fluorescence microscopy using ThT
fluorescence [65]. Although the study was done on a glass
surface, in principle it could be done on a membrane layer, in
order to monitor events during fibrillation at a membrane
interface.
5.4. Fluorescence studies of APP in cells
The expression of APP-YFP fusion protein in the COS-7
simian kidney fibroblast cell line showed localization to the
endoplasmic reticulum, Golgi, and plasma membrane, similar to
the localization of the Notch 1 receptor [66]. In order to study
possible protein–protein interactions a new method of bimole-
cular fluorescence complementation was employed. The
technique is based on co-expression of two target proteins:
one is fused to the N-terminal part of YFP, another is fused to
Fig. 8. Binding of aggregated DAC-Aβ to raft-like membranes at 37 °C. DAC-Aβ (100 μM) in 10 mM Tris/150 mM NaCl/1 mM EDTA buffer (pH 7.4) was
preincubated at 37 °C for (A) 0, (B) 4, (C) 8 and (D) 48 h. Immediately after dilution to 0.5 μM, the protein solutions were titrated with raft-like LUVs composed of
GM1/cholesterol/SM (2/4/4) and fluorescence spectra were recorded at an excitation wavelength of 430 nm. The numbers in the figure represent lipid-to-DAC-Aβ
ratios. Standard deviations at the peaks are shown by error bars (n=2). From Ref. [62].
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location) two parts of the fusion YFP self-assemble and form
functional fluorescent YFP. The detection of YFP fluorescence
in the cell expressing APP-N-YFP and Notch 1-C-YFP
indicates interaction between the two membrane proteins.
Interestingly, the expression of two variants of APP, APP-N-
YFP and APP-C-YFP, also show YFP fluorescence confirming
the dimerization of APP in the membrane in vivo [66].
Thus fluorescence experiments have shown that aggregated
A-beta effects membrane structure and properties more than
monomeric A-beta, suggesting that aggregated A-beta is more
cytotoxic and has greater effects on membrane permeability.
6. Prion protein folding, aggregation, and interaction with
membranes
Prions are infectious protein particles causing several human
and animal diseases including scrapie in sheep, bovine spongi-
form encephalopathy in cattle and Creutzfeldt–Jakob disease in
humans [67]. In these transmissible diseases, the cellular form
of the prion protein (PrPC) is converted into the infectious
scrapie isoform (PrPSc). The normal function of PrPC is
unknown; however, the protein may be involved in copperand zinc metabolism, cell signaling, synaptic transmission, and
cellular resistance to oxidative stress [68]. PrPC is a GPI-
anchored membrane protein, abundantly expressed in neurons
and other cell types. The protein has three structurally distinct
regions; the N terminal part (residues 23–90) is unfolded and
consists of four repeats (in humans) of PHGGGWGQ involved
in copper binding, whereas the C-terminal part (121–231)
consist of two motifs: a beta–helix–beta and a helix–turn–helix
fold stabilized by a disulfide bond [69,70]. The flexible middle
part (91–120) is important for fibril formation and undergoes a
transition to beta-sheet conformation during fibrillogenesis
[71,72]. The C-terminal domain also undergoes a conforma-
tional transition to more beta-sheet structure and constitutes the
majority of the fibril core, whereas the octarepeat region is not
required for fibril formation; however its conformation may
influence fibrillogenesis [73,74].
6.1. Interaction of the prion protein with membranes affects its
intrinsic tryptophan fluorescence
There are seven tryptophan residues in human PrPC, all of
them located in the N-terminal domain: five Trp are in the
repeats and two others are in the sequences flanking the repeats.
1876 L.A. Munishkina, A.L. Fink / Biochimica et Biophysica Acta 1768 (2007) 1862–1885Because PrPC is a membrane-anchored protein, the effects of
membranes on the protein structure and stability are important.
Several studies have addressed this issue by examining Trp
fluorescence in the presence of synthetic vesicles and micelles.
Analysis of the conformational changes in the N- and C-
terminal regions in the protein upon binding to synthetic
vesicles reveal that the Trp emission maximum of full-length
PrPC (23–231) is 348 nm indicating some solvent protection of
the Trp residues [75]. The same λmax is found in the fragments
23–145 and 90–231, corresponding roughly to the N and C-
terminal domains. The presence of negatively charged POPS
SUVs promotes a further blue-shift in the Trp maximum (to
340 nm) and an increase in intensity, which strongly depends on
pH. The changes in fluorescence intensity and λmax indicate
either binding to the lipid bilayer or vesicle-catalyzed folding/
self-association of PrPC. More acidic pH increases binding and
the apparent pKa is around six. The N-terminal fragment binds
to the lipid bilayer more strongly than the full-length protein,
and the 90–231 fragment does not bind at pH 7; however
binding is restored at pH 5, where the N-terminal region
changes conformation from random-coil to partially folded with
some parts forming α-helix as detected by far-UV CD [75].
However, these data are insufficient to identify the regions of
the protein that are responsible for the membrane binding. The
flanking regions for Trp31 and Trp99 are rich in Lys residues,
which can explain the specificity of binding to negatively
charged phospholipids. However the pH dependence may
reflect the involvement of His and thus the binding of the
octapeptide repeats [75].
Low pH or the presence of DPC micelles decreases the
intensity of Trp fluorescence but does not change the λmax. It is
only in the presence of DPC micelles at pH <6 that the blue shift
of Trp to ∼345 nm is detected [76]. The proposed structure of
the octarepeats in DPS micelles is different from the structure of
the octarepeats in aqueous solution at pH 6.2 [70]. Based on
these results, it appears that binding of the prion protein to
synthetic vesicles and micelles induces conformational changes
in both the full-length and octarepeat region of PrPC.
Interestingly, the changes depend on the lipid structure, which
may stabilize different conformations of PrPC.
6.2. Copper binding to the prion protein
The octarepeat region has a strong affinity for copper ions,
which is modulated by the ratio of copper to protein, pH, and the
presence of phospholipid micelles. At least three distinct
coordination modes of copper binding have been detected by
EPR analysis [77]. The first mode corresponds to high copper
occupancy and involves the HGGGW segment of each
octarepeat. The structure of the HGGGW–copper complex
has been solved by X-ray diffraction [78]. The second and third
modes correspond to intermediate and low copper occupancy
respectively. The third mode involves three His residues and
requires the presence of at least three octarepeats. Acidic pH
greatly influences copper affinity in the first mode of copper
coordination, because of instability of the glycine amide-copper
bonds at pH below 6.5 [77].The binding of copper strongly quenches Trp fluorescence,
which has been used to estimate the Kd of copper binding. The
apparent Kd of copper binding at high copper occupancy is
2.2×10− 7 M [76]. This is consistent with the value of Kd
obtained by CD [76], however it is order in magnitude smaller
than other published values [79,80]. The presence of DPC
micelles decreases the strong quenching effect of copper,
indicating weaker binding of copper (apparent Kd 10
− 5 M) in a
lipid environment. The decrease in binding has been confirmed
by CD and EPR [76]. It has been suggested that the pKa of the
His residue of the octapeptide is elevated in the presence of
DPC micelles and that this decreases binding to copper.
However, it is possible that conformational changes of the
octapeptide are incompatible with coordination of copper. The
structure of the octarepeat in DPC micelles is different from the
structures in aqueous solution and crystal, which explains the
low affinity for copper [70,78]. These observations indicate that
membranes may affect the conformation of the prion protein
and thus affect its propensity to aggregate, as well as its
function.
6.3. Prion PrP fibril formation detected by
immunofluorescence
The detailed structure of PrP fibrils remains unknown.
Various models have been proposed, however insufficient data
are available to confirm any particular model. In order to obtain
the necessary information an interesting novel approach has
been recently implemented [81], using fluorescent-labeled
antibodies that recognize distinct parts of the prion protein,
Fig. 9. The epitopes correspond to at least five different regions
of PrP, and two epitopes are specific to PrPSc and five others are
not. Because the very N-terminal part of the protein is highly
sensitive to proteinase K digestion, it is not part of the fibril core
and can be used as a reference corresponding to the exposed
regions within a fibril. All fibrils were double-labeled with a
reference antibody (with a covalently attached Alexa-546
fluorescence label) and an antibody to the other parts of the
protein (covalently labeled with Alexa-488). Analysis of
fluorescence microscopy images shows that the C-terminal
regions 159–174 and 224–230 are weakly labeled, whereas the
N-terminal region 95–105 has the same intensity of as the
reference antibody. The labeling of the 132–156 region is
moderate. The authors suggested that the C-terminal region of
PrP is buried in the fibril core and the N-terminal is exposed.
The region 132–156 is partially inaccessible and may be
involved in the assembly of protofilaments into a fibril. The data
are consistent with proteinase K digestion [82]. The labeling of
epitopes is increased by denaturation in guanidine hydrochlor-
ide. Interesting data were obtained with PrPSc epitopes 89–112
and 136–158, for which the antigenic region may not be a linear
sequence, because in the presence of Gdn.HCl there is little
antibody labeling. Three different types of antibody staining
were observed: some fibrils were apparently smaller in length
and width and can be labeled, whereas larger fibrils were either
incompletely or not stained. It is possible that some antibodies
recognize protofilament surfaces, which become inaccessible in
Fig. 9. PrPSc-specific IgG revealed conformational heterogeneity in population of amyloid fibrils. Shown is a fluorescence microscopy image of fibrils stained with
AG4/89–112 (red color) (A) and the same field of view showing the fibrils selected by the Colocalization Finder plug-in (WCIF Image J software) as 89–112-positive
fibrils (green color) (B), 89–112-negative fibrils (C), or fibrils with conformational polymorphism (D). Scale bars, 15 μm. From Ref. [81].
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interactions or conformational changes. Alternately, the obser-
vations may reflect a different type of heterogeneity in the fibril
population.
6.4. Yeast prion structure and fibril assembly
The original prion concept was widened with the discovery
of fungal proteins responsible for a non-Mendelian inherited
phenotype. These proteins can be infectious but not necessarily
toxic, rather their presence could be beneficial in certain
conditions [83]. Ure2p, Sup35p, Rnq1p, and HET-s form
amyloid fibrils in vitro, and their propagation in fungi
corresponds to their ability to aggregate. The fungal prions
are not homologous proteins and are not related to mammalian
PrP, and they have different functions. Ure2p is a repressor
controlling expression of ureidosuccinate permease, Sup35p is a
translation termination factor eRF3, Rnq1p is involved insporogenesis, and HET-s controls heterokarion incompatibility
and can trigger cell death. The yeast prions Sup35p and Ure2p
have been extensively studied.
6.5. Probing yeast prion amyloid fibril conformation by
excimer formation
Sup35p consists of three distinct regions: a glutamine/
asparagine-rich N-terminal containing four degenerative repeats
of QQYNPQGGY (designated N), a highly charged middle
region (M), and the C-terminal region corresponding to a GTP-
binding domain (C). The N and M parts are essential for prion
propagation in vivo and N is sufficient for forming amyloid
fibrils in vitro. In order to probe the structure of amyloid fibril
made of the N and M parts a new fluorescence approach has
been applied [84].
First, the folding of the protein was examined by labeling
with acrylodan at 37 distinct positions (by using 37 single Cys-
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mutants show emission maximum at 530 nm. After assembly
into fibrils, acrylodan-labeled mutants with Cys in the 21–121
region have maxima at 486–488 nm and a highly increased
fluorescence intensity, mutants with Cys in position 3, 137, 158,
and 167 have maxima at 493–525 nm and a moderate increase
in fluorescence, and mutants with Cys in position 2, 184, 225,
234 have no significant blue-shift and an increase in
fluorescence intensity. The data are consistent with a proposal
that the region 21–121 is folded and protected from solvent, the
close flanking regions are partially exposed, and the distant
flanking regions are unfolded and completely accessible to
solvent. The stability of these regions follows the same pattern:
21–121>137>158>7>2>184. The core region unfolds with
Cm=2.5 M Gdn.HCl, the others with Cms of 0.5–2 M. Gdn.
HCl-induced unfolding of the core region is identical to that of
the intact NM protein.
Second, the intermolecular contacts have been probed by
using pyrene-labeled proteins. Pyrene can form excimers if two
molecules of pyrene are closely located (4–10 Å). TheFig. 10. Intermolecular contacts in NM fibrils. (A) Proximity analysis assessed
by excimer fluorescence in fibrils carrying pyrene labels at single sites. The ratio
of excimer fluorescence/non-excimer fluorescence (I465/I375) is plotted. (B)
Excimer fluorescence in fibrils assembled from mixtures of two different
pyrene-labeled cysteine variants. Fibrils were assembled at 25 °C with gentle
rotation, in reactions containing equimolar mixtures of each variant (25%
labeled and 75% unlabeled). From Ref. [84].formation of excimers is indicated by the appearance of a
strong red shift of the fluorescence emission maximum. In the
unfolded state, the pyrene-labeled Cys mutants have λmax
between 384 and 405 nm. In the assembled state, most of the
labeled positions in the N region show a blue shift, indicating
that they are in a more hydrophobic environment and in the
folded region. The absence of excimer formation may
correspond to the long distance or unfavorable orientation of
the two pyrene molecules. There is also the possibility of
quenching. However, the pyrene labels of six Cys mutants
(positions 25, 31, 38, 91, 96, and 106) have red-shifted emission
maxima (∼465 nm), indicating that these positions are in close
proximity in the fibrils (i. e. 25 is close to 25, 31 to 31 etc.).
Further analysis of mixtures of two-Cys mutant combinations
confirms that the residues in either one of two regions 25–38 or
96–112 are close to each other. The region between them, 51–
73, corresponding to the repeats does not show any excimer
formation. The authors conclude that the assembly into fibrils
occurs through head–head and tail–tail interactions of the N
region and the central part of the N region constitutes the fibril
core, Fig. 10.
7. Immunoglobulin light chains structure, aggregation, and
interaction with membranes
Immunoglobulin (Ig) light chains are involved in several
diseases called light chain deposition diseases. The most
common of these is primary systemic amyloidosis (also
known as AL or light chain amyloidosis), the most common
of the systemic amyloidoses. These diseases are characterized
by accumulation of light chain aggregates that infiltrate various
tissues and organs and are most abundantly found in cardiac,
renal, and peripheral nerve tissues [85–87]. The accumulation
of extracellular fibrils or amorphous aggregates can be due to
the overproduction, incorrect processing, or particular sequence
variation of light chains.
7.1. Intrinsic tryptophan fluorescence of Ig light chains
The amyloidogenic variable domain of the representative
light chain SMA contains two Trp residues, Trp35 and Trp50
[88,89]. The fluorescence of Trp35 is quenched in the native
state by the adjacent disulfide bond, hence the unfolding of the
protein in 8 M urea or at pH 2 increases the fluorescence
intensity [89]. The λmax of Trp in the native state is ∼347 nm,
indicating partial exposure of Trp50 to solvent; upon denatura-
tion in 8 M urea the maximum is shifted to 355 nm.
Interestingly, at pH 2 the maximum is not red-shifted but
blue-shifted (345 nm), indicating that the two denatured states
are different. Indeed, pH 2 promotes fibril formation, whereas
8 M urea inhibits aggregation. Because the pH 2-denatured state
shows Trp protection, it corresponds to a partially folded
conformation. Intrinsic Trp and ANS fluorescence experiments,
along with other techniques, have demonstrated that the
amyloidogenic light chain SMA forms two partially folded
intermediates, one with significant structure and which is
maximally populated around pH 5, the other, which is
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correlates with amorphous deposition and the latter with fibrillar
deposits [89].
7.2. Effects of membranes on Ig light chain aggregation
Amyloidogenic LCs have been shown to preferentially
interact with caveolae in the membranes of mesangial cells [90],
and the deposits are most commonly found associated with the
basement membranes of the extracellular matrix. Thus it is
possible that membrane surfaces play an important role in light
chain fibril deposition. To investigate the role of membranes
and their composition on immunoglobulin light chain aggrega-
tion, SUVand LUVof various combinations of lipids have been
tested on SMA fibrillogenesis [91]. SMA has been shown to
bind to negatively charged surfaces [92] and as a result,
negatively charged vesicles of POPA promote SMA fibril
formation, as monitored by Thioflavin T fluorescence. The
addition of lipid vesicles to SMA does not change the Trp
fluorescence intensity or λmax, however small changes are
detected by CD and ANS anisotropy, indicating the destabiliza-
tion of beta-structure [91]. The absence of changes in Trp
fluorescence may correspond to compensatory effects on the
two Trp residues or their conformational changes and interac-
tion with the lipid bilayer.
Consequently, based on the effects of vesicles of certain lipid
composition in accelerating the rate of light chain fibrillation,
detected by ThT fluorescence, we can conclude that membranes
may be important factors in the etiology of light chain
amyloidosis.
8. Transthyretin structure, aggregation, and interaction
with membranes
Transthyretin (TTR) is a hormone (thyroxine) carrier,
circulating independently in cerebrospinal fluid (CSF) and
blood, because it cannot cross the blood brain barrier. TTR also
carries retinol-binding protein in the blood. TTR is a tetramer of
beta-sandwiches [93] and is involved in several amyloid
diseases including senile systemic amyloidosis (SSA), familial
amyloid cardiomyopathy (FAC), familial amyloid polyneuro-
pathy (FAP), and central nervous system selective amyloidosis
(CNSA) [94]. SSA is associated with deposition of wild type
TTR in the heart, whereas the familial amyloidoses are
characterized by deposition of mutant TTR in the heart,
peripheral nerves, or CNS. The accumulation of TTR deposits
lead to organ dysfunction and death.
8.1. Detection of oligomers, protofibrils, and fibrils of TTR by
fluorescent dyes
A combination of different fluorescence probes has been
used to investigate the fibrillation of TTR [95]. In addition to
ANS, bis-ANS and ThT, DCVJ was used. DCVJ is a molecular
rotor containing a fluorescent julolidine moiety and an intrinsic
dicyano quencher. In solvents that permit free rotation of the
dicyano group, DCVJ is quenched. However, if the torsionalrigidity of the medium is increased, the DCVJ quantum yield
(fluorescence intensity) is also increased. The stabilization of
DCVJ is observed during polymerization of microtubules, actin,
and TTR fibrillation. Interestingly, the kinetics of ANS, bis-
ANS, DCVJ, and ThT fluorescence during TTR aggregation are
different. Bis-ANS fluorescence rapidly decreases and DCVJ
fluorescence increases at a similar rate; however, the kinetics of
fluorescence changes for ANS and ThT fluorescence are much
slower. The decay of bis-ANS fluorescence can be attributed to
the disappearance of the native tetramer, whereas ANS detects
the appearance of a transient oligomer and slow maturation of
fibrils in which hydrophobic patches become buried. ThT
fluorescence reflects protofilament and fibril formation, the
latter being the slowest process.
8.2. Transthyretin interaction with membranes
The binding of wild type and the mutant forms of TTR, L55P
and V30M, to plasma membrane preparations and synthetic
liposomes has been analyzed by using surface plasmon
resonance [96]. Synthetic vesicles were made of phospholipids,
sphingomyelin, and cholesterol (DMPC, DMPE, DMPS,
sphingomyelin, and cholesterol in a 6:5:2:2:5 molar ratio as
found in grey brain matter). The analysis shows that aggregated
forms of wild-type, L55P, and V30M TTR interact with both
plasma membrane and synthetic vesicles, and the most
aggregation-prone form, L55P, has the strongest binding. To
analyze the effects of TTR binding on membrane fluidity a DPH
anisotropy fluorescence assay was used [96]. DPH is located in
the hydrocarbon core of the lipid bilayer, thus a decrease of its
anisotropy corresponds to an increase in its rotational and lateral
mobility, which reflect the dynamics of the surrounding acyl
chains. An increase in temperature leads to the transition of
lipids from the gel-phase to the liquid crystalline phase and to a
decrease in DPH anisotropy. The transition for plasma
membrane (intact and depleted of membrane proteins) does
not show a point of inflection, indicating a broad Tm, whereas
synthetic lipid vesicles mimicking neuronal membranes have a
Tm around 37 °C. The addition of aggregates of V30M and
L55P decreases the DPH anisotropy in synthetic vesicles and
plasma membrane preparations, whereas wild type TTR
aggregates did not significantly affect the membrane fluidity.
It is important to note that the degree of aggregation is different
among the three types of TTR: L55P is more aggregated than
V30M, and wild type does not show significant aggregation
[96]. Overall this work demonstrated that aggregated TTR
interacts with membranes and changes their properties by
increasing membrane fluidity. This destabilization of mem-
branes may cause various outcomes ultimately leading to cell
death.
9. Serum amyloid A structure, aggregation, and
interaction with membranes
Serum amyloid A (SAA) is one of the major proteins
produced by the liver in response to inflammation. Its plasma
concentration rises 100–1000-fold over 1–2 days. However its
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[97]. SAA is responsible for inhibition of antibody production,
modulates chemotaxis of leukocytes, is involved in anti-platelet
and anti-tumor growth and migration, inhibits oxidative bursts
produced by neutrophils and macrophages, and cholesterol
metabolism [97]. Most of the SAA in plasma is associated with
HDL. As with most apolipoproteins, SAA exists in an α-helical
conformation, and the α-helicity is increased upon binding to
lipid membranes [98]. SAA is a precursor of amyloid A, a
principal constituent of the deposits associated with persistent
inflammation leading to secondary systemic amyloidosis (AA
amyloidosis) during various diseases such as adult rheumatoid
arthritis, juvenile chronic arthritis, hereditary inflammatory
diseases such as familial Mediterranean fever, familial cold
urticaria, Muckle–Wells syndrome, and tumor necrosis factor
receptor-associated periodic syndromes [99,100]. The predomi-
nant targets of AA deposition are the kidneys, spleen, and liver.
9.1. Serum amyloid A interaction with membranes
Human SAA has two isoforms SAA1 and SAA2. SAA1 is
insoluble at neutral pH imposing technical difficulties for
structural studies. The secreted form of SAA1 has 104 amino
acid residues and is relatively enriched in aromatic residues:
there are eight Phe, four Tyr, and three Trp. The formation of
aromatic clusters could be important for the physiological
function of SAA such as binding to cholesterol and HDL. It is
also likely that aromatic residues are involved in SAA self-
assembly. The purification of SAA from HDL indicates that
SAA exists as an oligomer [98,101]). SAA has similar
properties to other apolipoproteins: it is purified from HDL,
has α-helical conformation, and forms discoidal particles in the
presence of multilamellar (MLV) DMPC vesicles [98]. The
binding to MLV DMPC was confirmed by Trp fluorescence: the
emission maximum is shifted from 357 nm to 334 nm,
indicating that Trp residues are buried in a hydrophobic
environment. Surprisingly, there is no shift of the Trp λmax in
the presence of DMPC SUV, however the intensity of Trp is
increased. This shows that SAA binds strongly to MLV but not
SUVof DMPC. It has been shown that SAA can form pores in
planar lipid membranes and its expression in bacteria induces
cell lysis [102].
9.2. Monitoring serum amyloid A accumulation in
macrophages
It has been proposed that macrophages are key players in
SAA amyloid formation. Numerous histological studies show
close proximity of macrophages and SSA amyloid and dense
fibrillar inclusions in mononuclear cells. SAA fibrils have been
identified in lysosomes, along cell membranes, and extracellu-
larly [103–105]. To understand how SAA is accumulated in
macrophages and its conversion into amyloid, fluorescently-
labeled SAA has been added externally to tissue culture of
peritoneal macrophages and its fluorescence has been mon-
itored by confocal fluorescence microscopy [106,107]. SAA is
colocalized with LDL in cells, indicating that SAA follows thesame trafficking as LDL, from endosomes to lysosomes. After 2
days the SAA fluorescence is lost, indicating degradation of
SAA. However, in the presence of the enigmatic amyloid
enhancing factor (AEF; thought to be seeds of SAA fibrils)
purified from the spleens of mice with chronic inflammation,
SAA degradation is slowed and SAA is accumulated not only in
endosomes and lysosomes but also in larger vesicles [106,107].
After 10 days, the localization of SAA aggregates is changed
from intracellular to extracellular.
10. Apolipoprotein structure, aggregation, and interaction
with membranes
Apolipoproteins are the protein constituents of various
density lipoprotein particles abundantly present in the plasma.
Based on the major protein constituent, lipoproteins can be
divided into two classes. Apo AI and Apo AII are the main
components of high density lipoproteins (HDL), whereas apoB,
apoE, apoC are mostly associated with low density lipoproteins
(LDL and VLDL) [108]. Apolipoproteins are involved in the
recycling, transport, and redistribution of lipids (cholesterol,
triacylglycerides, phospholipids) across the body [109]. During
hypercholesterolemic states apolipoproteins accumulate in the
intima (the inner cells of the artery walls) and form amyloid
fibrils which are components of atherosclerotic plaques.
Deposits of wild type apolipoproteins AI, AII, AIV, CII, and
E have been identified in the aortas of elderly individuals [110].
In addition, nine autosomal dominant mutations of the AI gene
are associated with familial amyloid polyneuropathy III [111].
The amyloid fibrils are made of the C-terminally truncated
protein, 83–100 amino acid residues in length. The N-terminal
is unfolded at neutral pH and adopts an α-helical conformation
in acidic conditions [111]. Apolipoprotein AII aggregates are
associated with hereditary renal amyloidosis, in this case the AII
protein is extended due to a mutation in the stop codon [112].
10.1. Intrinsic tryptophan fluorescence of apolipoproteins
Far-UV CD and crystallographic data indicate that apolipo-
proteins are α-helical proteins and that binding to lipids
increases their α-helicity. Structural analysis of apolipoproteins
sequences reveals that they can form amphipathic α-helices and
that the Trp residues are located on their hydrophobic surfaces
[113]. The binding to MLV and SUV results in an increase of
Trp fluorescence intensity and a blue-shift of Trp maximum
[98].
Single Trp mutants of Apo AI have been used to study each
of eight 22-mer repeats corresponding to eight amphipathic α-
helices [114]. The naturally occurring Trp were substituted by
Phe residues. All Trp mutants can be reconstituted into two
types of HDL (high and low lipid to protein ratio) and show
λmax between 322 and 332 nm, indicating a highly hydrophobic
environment for Trp. Interestingly, W130, W196, and W229
have the lowest λmax, which may indicate the tightest binding to
HDL. The binding of apoAI helices to two different types of
HDL varies: the major changes occur in helices 5, 7, and 8.
Most of the changes correspond to a blue-shift of λmax in larger
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however the λmax of W174 (helix 7) is red-shifted and no
changes are observed for W53 (helix 1). The fluorescence of all
the Trp mutants can be efficiently quenched by the membrane-
bound dye 12-nitroxide-DSPC, whereas there is little quenching
by acrylamide. Only W152 (helix6) shows partial accessibility
to acrylamide quenching. The authors suggested that the
domain comprising helices 5, 6, and 7 undergoes rearrangement
depending on HDL composition and that may reflect the
changes occurring during formation of spherical HDL from
discoidal particles.
10.2. FRET studies of apolipoprotein in discoidal HDL
To study the changes in Apo AI conformation upon
formation of spherical HDL from discoidal HDL particles,
FRET analysis has been done by using single Cys mutants
labeled with fluorescein and tetramethylrhodamine [115].
Cys132 and Cys154 are located in helices 5 and 6 and FRET
analysis allows estimation of their relative orientation. The
reconstructed discoidal HDL particles contain two Apo AI
molecules and have 98 Å hydrodynamic diameters. FRET
results are partially consistent with a belt model of apoAI which
is based on the X-ray crystal structure of lipid-free Apo AI. The
data show the antiparallel arrangement of two helices of Apo
AI, where helix 5 of one molecule is in the close proximity to
helix 5 of another molecule, and helices 6 from the two
molecules are very distant. However, the results also indicate
the presence of other arrangements of Apo AI. The authors
proposed a flexible belt model, which allows relative rotation of
circular molecules of Apo AI and could result in the observed
distribution of values obtained by time-resolved FRET. The
formation of spherical HDL particles leads to incorporation of
three Apo AI molecules per HDL and lowering of FRET
efficiency.
Single cysteine mutants (Cys9 (helix 1), Cys124 (helix 5),
and Cys 232 (helix 10)) of Apo AI labeled with Alexa-488
(fluorescein derivative) and Alexa-546 (rhodamine derivative)
were used in time-resolved FRET studies of Apo AI in discoidal
HDL [116]. Homo-FRET of Apo AI labeled with Alexa-488
was also employed. The Förster critical distance R0 for homo-
FRET is 5.0 nm and for hetero-FRET is 5.6 nm. FRET data
show that the distances between the same helices are around 5–
6 nm, which is inconsistent with the belt model and consistent
with two hairpin models in which two molecules of Apo AI are
arranged in both head-to-head and head-to-tail orientations.
Thus, fluorescence experiments indicate the existence of
multiple interactions of Apo A1 with HDL.
11. Islet amyloid polypeptide structure, aggregation, and
interaction with membranes
Islet amyloid polypeptide (IAPP), also called amylin, is a 37-
amino acid peptide–hormone produced primarily in the beta-
cells of the pancreatic islets [117]. IAPP is involved in many
processes associated with feeding and maintenance of bone
cells, renal proximal tubular cells, and islet beta-cells [118].Human IAPP amyloid deposits are found in the islets of
Langerhans in the pancreas and their accumulation is associated
with type 2 diabetes mellitus characterized by beta-cell loss and
severe impairment of insulin production [119].
11.1. Intrinsic tyrosine fluorescence of IAPP
There are three aromatic residues in the peptide: F15, F23,
and Y37, Fig. 1. The intrinsic fluorescence of Tyr37 has been
used as a probe to monitor conformational changes of IAPP
during fibrillogenesis [120]. Excitation at 278 nm gives similar
emission spectra with λmax at 303 nm for monomeric IAPP,
mixtures of oligomeric and monomeric IAPP, and control
acetylated Tyr. However, in the fibrils the emission maximum
and intensity are changed, indicating a different Tyr environ-
ment. The authors suggested that the effect could be due to
hydrogen bonding of the Tyr. The measured pKa of Tyr in the
fibrils is 11.9 and higher than the regular Tyr pKa, which is
around 10. The excitation spectrum (λmax at 303 nm) is also
broadened and shows a significant increase in the 250–260 nm
region in fibrillar and to a lesser extent in oligomeric IAPP. This
is indicative of Phe excitation and FRET between Phe and Tyr
residues. The calculated distance between Y37 and F23 or F15
is around 10–11 Å in the fibril and 12–14 Å in the oligomer (the
critical distance R0 is 12.5 Å). Previous studies have identified
residues 20–29 as the core structure of the fibrils. The FRET
data suggest that Y37 and F23 or F15 form an aromatic cluster,
which could be important for protofilament assembly into
fibrils. This conclusion is also supported by the decreased
accessibility of Tyr to quenching by iodine or acrylamide and
the increased anisotropy of Tyr in fibrils.
11.2. IAPP interaction with membranes
Self-association of IAPP leads to changes in the interaction
with membranes [121]. Polymerized DMPC lipid vesicles
containing C6-NBD-PE were used as model membranes. NBD
fluorescence is quenched by the addition of dithionite. In the
presence of IAPP, NBD fluorescence is more accessible to
dithionite quenching. The analysis of aliquots of solution during
IAPP fibril formation shows that the early soluble (supernatant)
fractions containing oligomers and protofilaments have the
strongest effect on NBD quenching, whereas fibrils are much
less effective. The increase in NBD quenching can be attributed
to perturbations in the lipid bilayer resulting in faster
penetration of dithionite. The disruption of DMPC vesicles
was confirmed by colorimetric assay and electron microscopy.
The results are consistent with several studies showing higher
levels of cytotoxicity of protofilaments and oligomers in cell
cultures and stronger effects of prefibrillar species on the
disruption of membranes.
12. Effects of oligomeric IAPP, A-beta, and prion protein
on calcium release in live cells
Monomeric, oligomeric, and fibrillar forms of several
amyloidogenic proteins or their fragments including IAPP, A-
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examined in calcium-homeostasis assays in vivo in SH-SY5Y
human neuroblastoma cells [122]. The intracellular calcium was
detected by Fluo-3 and calcein, specific fluorophores that
fluoresce strongly upon binding calcium. The addition of
monomers or fibrils does not affect the intracellular calcium
level, whereas oligomeric species of all tested amyloidogenic
proteins greatly increased the intracellular free calcium levels.
The effect is similar to the action of the calcium ionophore
ionomycin. The increase in fluorescence, Fig. 11, is observed
almost immediately and reaches a maximum in 10–20 s. The
addition of thapsigargin, a specific inhibitor of the calcium
ATPase pump located in the endoplasmic reticulum (ER),
results in a slight accumulation of intracellular cytosolic
calcium, however this does not prevent the large increase in
calcium level after addition of amyloidogenic protein oligo-
mers, indicating that calcium elevation is due to extracellular
calcium influx. In the absence of extracellular calcium, the
addition of oligomers leads to a slight elevation of cytosolic
calcium similar in intensity to treatment with thapsigargin.
Interestingly, the response occurs over more than 100 s and
indicates the calcium release is from intracellular compartments.
The prolonged response may point to either the time needed for
oligomers to reach the ER by diffusion or transport or activation
of intracellular signal transduction pathways leading to the
calcium release. The calcium influx activated by oligomers does
not require endogenous plasma membrane calcium channels
because the addition of inhibitors of calcium channels such asFig. 11. Aβ42 oligomers, but not monomers or fibrils, elevate intracellular free [Ca2+]
loaded SH-SY5Y cell in response to sequential application of monomers, fibrils, and o
the cell were captured at the times indicated during the trace and are depicted on a pse
fluorescence. (B) Trace shows the average responses from 22 cells, evoked using thcobalt and 6-cyano-7-nitroquinoxaline-2,3-dione have no
effects on calcium influx in the presence of the oligomers. It
has been suggested that oligomers increase the plasma
membrane permeability by disrupting membrane integrity, a
conclusion also supported by the increased leakage of the
fluorescent dyes fluo-3 and calcein. The increased permeability
and disruption of membranes may be the primary effects of
oligomers responsible for the induction of cell death.
13. Conclusions
Amyloidogenesis is a characteristic feature of protein
deposition diseases. Accumulating evidence strongly indicates
that self-association of misfolded proteins into either fibrils,
protofibrils, or soluble oligomeric species is cytotoxic. The
question of how the self-associated forms induce cell death
remains open. It has been proposed that fibrillar (or
protofibrillar) aggregates induce the inflammatory response
that eventually results in cell death. A significant increase in
amyloidogenic protein concentration or the presence of factors
or conditions that promote destabilization of the native
structure (e. g. metals, lipids, oxidants, acidic pH, high
temperature, the absence of stabilizing ligands) results in the
formation of misfolded protein structures with a high
propensity to self-associate. Interestingly, the majority of
soluble oligomeric species present during the aggregation/
fibrillation process are high in beta-sheet content, as is found in
fibrils.. (A) Time course of Ca2+-dependent fluorescence recorded from a single fluo-3-
ligomers of Aβ42 (each at a final concentration of 6 μg/ml). The inset images of
udo color scale with “warmer” colors on a rainbow scale corresponding to higher
e same protocol. Error bars indicate ±1 S.E. From Ref. [122].
1883L.A. Munishkina, A.L. Fink / Biochimica et Biophysica Acta 1768 (2007) 1862–1885The interaction of several amyloidogenic polypeptides with
membranes leads to perturbation of membrane structure,
suggesting both that such a phenomenon is probably common
to all amyloidogenic polypeptides, and that the resulting
increased permeability of the membrane due to the interaction
with the aggregated protein leads to cytotoxicity.
A variety of different fluorescence techniques have con-
tributed to these findings, demonstrating the importance of
fluorescent methods in the study of amyloidogenesis and
membrane interactions. Needless to say many other comple-
mentary techniques have also been used, either to extend or
corroborate the fluorescence data. However, fluorescence
methods are particularly valuable in studying the effects of
the amyloidogenic proteins on membrane properties, since there
are few alternatives. New fluorescence-based technologies to
investigate amyloidogenesis and membrane interactions of
amyloidogenic protein are continuously being developed. As
a consequence we can expect additional insights into the
complex mechanisms of protein aggregation and its effects on
membranes to continue at a significant rate.
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